Shareholding disclosure
Santhera Pharmaceuticals Holding AG
Collectively declared rate
3%
Threshold
Fell below threshold
Timeline
Published
12.01.2011
Transaction
07.01.2011
Transfer date
07.01.2011
Voting rights breakdown
Voting rights acquired0%
Voting rights sold0%
Below threshold3%
Declared beneficial owners · 2
A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.
Notice details
CategoryGroup of shareholders
ExchangeXSWX
Notification ID
TBB1B00022
Beneficial owner
Jonathan J. Fleming
Declared address
Jonathan J. Fleming, Newton MA 02462
OBP Management III L.P. is the General Partner of - Oxford Bioscience Partners III L.P. - Oxford Bioscience Partners (Adjunct) III L.P. - mRNA Fund L.P. OBP Management (Bermuda) III L.P. is the General Partner of - Oxford Bioscience Partners (Bermuda) III L.P.
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open